title: Advances in percutaneous coronary intervention in patients with chronic kidney disease.
abstract: Coronary artery disease is the number one cause of death in patients with chronic kidney disease (CKD). However,patients with impaired renal function are much less likely than patients with normal renal function to undergo left heart catheterization and coronary intervention. Patients that do receive invasive strategies experience more bleeding and higher rates of ischemic events. In this review, we examine advances in percutaneous coronary intervention--including antiplatelet therapy and drug-eluting stents--and their impact on patients with CKD.
authors.affiliation: Department of Internal Medicine (Cardiovascular Medicine), University of Missouri, Columbia, Missouri 65212, USA.
authors.forename: Walter C
authors.initials: WC
authors.lastname: Coats
authors.forename: Kevin C
authors.initials: KC
authors.lastname: Dellsperger
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D003327:Coronary Disease / Q000150:complications / Q000628:therapy*; D054855:Drug-Eluting Stents; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D051436:Renal Insufficiency, Chronic / Q000150:complications*
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex